MacroGenics, Inc. (MGNX)
1.92
+0.19
(+10.98%)
USD |
NASDAQ |
Feb 25, 16:00
1.92
0.00 (0.00%)
After-Hours: 16:50
MacroGenics Research and Development Expense (Quarterly) : 30.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Amicus Therapeutics, Inc. | 23.74M |
| Merck & Co., Inc. | 3.992B |
| CorMedix, Inc. | 5.098M |
| Xencor, Inc. | 54.37M |